Intellia Therapeutics, Inc. (NTLA)

13.47 +0.86 (+6.82%) USD  |  NASDAQ  |  May 27, 11:46
More

Intellia Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Twist Bioscience Corp. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade